Skip to main content
Jenkem Technology Co., Ltd. logo

Jenkem Technology Co., Ltd. — Investor Relations & Filings

Ticker · 688356 ISIN · CNE1000043K9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 569 across all filing types
Latest filing 2025-04-28 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688356

About Jenkem Technology Co., Ltd.

https://www.jenkem.com/

Jenkem Technology Co., Ltd. specializes in the research, development, and large-scale manufacturing of high-purity polyethylene glycol (PEG) derivatives and related polymers. The company provides a comprehensive portfolio of PEG products, including monodisperse and polydisperse PEG linkers, multi-arm PEGs, and functionalized derivatives such as NHS esters, maleimides, and amines. These materials are primarily utilized in advanced drug delivery systems, PEGylation of proteins and peptides, and the development of medical devices and hydrogels. In addition to its core PEG offerings, the company produces biodegradable polymers, including PLA, PLGA, and PCL. Jenkem Technology supports the global biotechnology and pharmaceutical sectors through custom synthesis and high-quality manufacturing processes designed to meet rigorous technical specifications for therapeutic and diagnostic applications.

Recent filings

Filing Released Lang Actions
独立董事2024年度述职报告（高巧莉）
Board/Management Information Classification · 95% confidence The document is titled '2024 年度独立董事述职报告' which translates to '2024 Annual Independent Director's Work Report'. It is a detailed report by an independent director about their duties, attendance at board and shareholder meetings, communication with auditors, and oversight activities during the year 2024. The content focuses on the director's responsibilities, evaluations, and governance-related activities rather than financial results or audit opinions. It does not contain financial statements or earnings data, nor is it an announcement or proxy solicitation. The document is a management-related report focusing on board and director activities, fitting best under Board/Management Information (MANG). The document length is 4300 characters, which is consistent with a detailed report but not a full annual report or audit report. Therefore, the classification is MANG with high confidence.
2025-04-28 Chinese
关于会计师事务所2024年度履职情况评估报告
Audit Report / Information Classification · 95% confidence The document is an evaluation report on the performance of the accounting firm Deloitte Huayong for the year 2024, detailing their qualifications, audit procedures, quality management, and overall assessment related to the company's annual audit. It references the 2024 annual audit engagement and the audit firm's role in the company's 2024 annual report audit. The document is not the annual report itself but an audit-related report focusing on the auditor's performance and quality management. It is a standalone audit report or information about the audit firm’s performance and compliance, not the full annual report or financial statements. The document length is 4436 characters, which is relatively short but contains substantive audit-related content, not just an announcement or certification. Therefore, it fits best under the category Audit Report / Information (AR). FY 2024
2025-04-28 Chinese
关于自愿披露全资子公司取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the voluntary disclosure of its wholly-owned subsidiary obtaining a medical device registration certificate. It includes product details, impact on the company, and risk warnings. There is no financial data, no mention of a report being attached or published, and no regulatory certification or officer attestation. The content is an official announcement about a business development event rather than a financial report or regulatory filing. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-04-25 Chinese
关于召开2024年度暨2025年第一季度业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling and details of an upcoming performance explanation meeting (业绩说明会) for the 2024 annual and 2025 first quarter results. It provides the date, time, location, participation method, and contact information for the meeting. It does not contain actual financial data or detailed financial analysis but rather informs investors about the event where such information will be discussed. The document length is short (1432 characters), and it serves as a notice for an investor presentation event rather than the presentation or report itself. Therefore, it fits the category of an Investor Presentation announcement (IP).
2025-04-21 Chinese
2024年度业绩快报公告
Earnings Release Classification · 95% confidence The document is titled as a "2024 年度业绩快报公告" which translates to "2024 Annual Performance Express Report Announcement." It contains preliminary financial data for the full year 2024, including revenue, profit, net profit attributable to the parent company, earnings per share, and asset information. The data is explicitly stated as preliminary and unaudited, with a disclaimer that the final audited data will be in the company's 2024 annual report. The document is relatively short (2175 characters) and serves as a quick earnings update rather than a full comprehensive annual report. This type of document is typically classified as an Earnings Release (ER) because it provides key highlights of financial results for the year but is not the full annual report (10-K) or audited financial statements. It is not a report publication announcement (RPA) because it contains substantive financial data, not just a notice of report availability. FY 2024
2025-02-27 Chinese
关于股份回购实施结果暨股份变动的公告
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement about the company's share repurchase (buyback) implementation results and changes in shareholding. It includes specifics such as the number of shares repurchased, prices, approval details, usage of repurchased shares, and compliance with regulatory requirements. The text explicitly mentions the repurchase of shares, the purpose (employee stock ownership plan or equity incentives), and the handling of repurchased shares. This matches the definition of a Transaction in Own Shares (POS) filing, which covers reports of the company buying back or selling its own shares. The document is not a general regulatory announcement, nor is it a full financial report or earnings release. It is also not a short announcement of a report publication but a substantive disclosure of share repurchase details. Therefore, the correct classification is POS with high confidence.
2025-02-20 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.